Ribozyme and omics

Anti-cancer development based on RNA Platform technology Core competence to meet diverse unmet medical needs

Introduction

Ribozyme and omics

Anti-cancer development based on RNA Platform technology Core competence to meet diverse unmet medical needs

Vision

Implementation of cancer conquest through innovative RNA-based
anti-cancer biopharmaceutics

Objective and Unit

Platform

RNA Replacement Enzyme
(Trans-splicing ribozyme)